CALR and cancer: Once ICD was triggered by anti-cancer therapy, the release of many damage-associated molecular patterns (DAMPs), such as cell surface-exposed calreticulin (CALR), extracellular adenosine triphosphate (ATP), could drive the activation and maturation of innate and subsequent adaptive immune cells [39].